Results: The study was terminated after the interim analysis. The intention-to-treat
population consisted of 208 patients enrolled in 20 centers, of whom 105 received …

Background and study aims Rectal nonsteroidal anti-inflammatory drug (NSAID) prophylaxis
reduces incidence of post-endoscopic retrograde cholangiopancreatography (ERCP) …

Background: Octreotide is a potent inhibitor of pancreatic secretion, and corticosteroids
suppress humoral and cellular activity. Both agents may reduce the frequency of post-ERCP …

BACKGROUND: Pentoxifylline can ameliorate pancreatitis in animal models because of its
anti–tumor necrosis factor properties. OBJECTIVE: Our purpose was to study the safety and …

We read with great interest the article by Choi et al 1 and the elegant accompanying editorial
by Singh 2 using vigorous peri-procedural intravenous hydration with lactated Ringer's …

Aim: Pentoxifylline may prevent post-ERCP pancreatitis due to its anti-TNF properties. The
aim of this study was to examine the safety and efficacy of pentoxifylline for the prevention of …

Background: The most common serious complication of endoscopic retrograde
cholangiopancreatography (ERCP) is acute pancreatitis. Currently, temporary pancreatic …

Therapeutic ercp has become an accepted interventional method for both biliary and
pancreatic diseases despite complications. post-ercp pancreatitis, a complication associated …

Endoscopic retrograde cholangiopancreatography (ERCP) is a diagnostic and therapeutic
procedure employed in the management of disorders of the biliary system. Post-ERCP …

BACKGROUND: Biochemical markers of ERCP-related myocardial injury have not
previously been investigated. OBJECTIVE: To evaluate ERCP-related cardiac troponin I …